| Gonococcemia | |
|---|---|
| Other names | Disseminated gonococcal infection [1] | 
|   | |
| Neisseria gonorrhoeae | |
| Specialty | Infectious diseases   | 
| Symptoms | Fever, multijoint pain, hemorrhagic pustules | 
| Complications | Rarely leads to meningitis and endocarditis | 
| Causes | Neisseria gonorrhoeae infection | 
| Risk factors | unprotected sex, female sex | 
| Diagnostic method | Nucleic Acid Amplification Techniques (NAAT) | 
| Treatment | Cephalosporins or Fluoroquinolones | 
Gonococcemia (also known as "Disseminated gonococcal infection" [1] ) is a rare complication of mucosal Neisseria gonorrhoeae infection, or Gonorrhea, that occurs when the bacteria invade the bloodstream. [2] It is characterized by fever, tender hemorrhagic pustules on the extremities or the trunk, migratory polyarthritis, and tenosynovitis. [3] Patients also commonly experience joint pain (e.g. knee) due to the purulent arthritis. [4] It also rarely leads to endocarditis and meningitis. [5] This condition occurs in 0.5-3% of individuals with gonorrhea, and it usually presents 2–3 weeks after acquiring the infection. [6] Risk factors include female sex and infection with resistant strains of Neisseria gonorrhoeae. This condition is treated with cephalosporin and fluoroquinolone antibiotics. [5]
 
 Neisseria gonorrhoeae is a gram negative diplococcus (also referred to as "Gonococcus") and a pathogenic bacteria. [2] In 2019, there were 616,392 reported cases of gonorrhea in the United States, with an overall increased rate 5.7% from 2018 to 2019. [7] Among those approximately 600,000 cases, it is estimated that 0.5-3% of gonorrheal infections result in gonococcemia. This condition is more common in women, affecting approximately 2.3-3% of women with gonorrhea and 0.4-0.7% of men. [5] This discrepancy is explained by increased incidence of silent gonorrheal infections in females and an increased rate of transmission to females that have sexual intercourse with infected males. [6] Gonococcemia also occurs more frequently in pregnant women, those with recent menstruation, and those with IUDs. [6]
Treatment typically consists of cephalosporin and fluoroquinolone antibiotics. [5] Gonococcemia is typically treated with intravenous or intramuscular cephalosporin antibiotics. [6] Approximately 10-30% of gonorrheal infections present with a co-infection of chlamydia, so it is common to add a one-time dose of oral azithromycin or doxycycline for coverage of Chlamydia trachomatis . [6] Bacterial resistance to antibiotics is increasingly common in Neisseria gonorrhoeae, so it is often advised to check susceptibility of the bacterial culture and then adjust the antibiotic therapy as needed. [5]
Neisseria gonorrhoeae is transmitted during sexual contact with an infected individual. The bacteria invade the non-ciliated columnar epithelium of the urogenital tract, oral mucosa, or anal mucosa following exposure. [2] Invasion of the host cells is made possible due to virulence factors such as Pili, LOS, Opa, and others. [2] Similarly, these virulence factors can be used for avoiding the host immune system, which may explain prolonged infection, bacterial resistance, and gonococcemia. [3]
